(a) Cultured human cells, either A375 melanoma cells or fibroblasts with NER deficiencies, were subjected to a single UVB dose (20 J/m2) during approx. 2 seconds. Following recovery, cellular DNA was subsequently assayed for subclonal mutation in the RPL13A -116 bp TTCCG promoter hotspot site (see Fig 1a and 1b, top row) using SiMSen-Seq error-corrected amplicon sequencing [23]. Non-UV-treated sample were included as controls. (b) 10 samples were sequenced at 311k to 950k reads each, resulting in 7.3k to 13.8k error-corrected reads at ≥10x oversampling. (c) Subclonal mutations in a 46 bp amplicon window encompassing the RPL13A -116 bp hotspot in A375 melanoma cells. The hotspot site and TTCCG element are indicated in gray/red, respectively. Positive axis, UV-treated sample; negative axis, no UV control. (d-g) As panel c but showing results from XPC -/- (lacking global NER), XPA -/- (lacking global and transcription-coupled NER), ERCC8 -/- and ERCC6 -/- (lacking transcription-coupled NER) mutant fibroblasts.